Skip to NavigationSkip to content

News

Apellis Pharmaceuticals has revealed new Phase 3 demonstrating that its targeted C3 inhibitor pegcetacoplan met its primary endpoint and outclassed...
Pharmacy chains have argued in federal court that doctors and healthcare practitioners who write prescriptions bear ultimate responsibility for the...
The FDA announced today that it has approved a new alternative surgical technique for Abbot’s HeartMate 3 heart pump.
Indian pharma firm Glenmark has announced it has secured approval from the FDA for its oral deferasirox tablets in the treatment of high iron...
Bavencio (avelumab), the anti-programmed death ligand-1 (PD-L1) antibody co-developed by Pfizer and Merck KGaA’s biopharma unit EMD Serono, has...
MSD has lifted the curtain on new Phase 3 data on the efficacy of its blockbuster immunotherapy Keytruda, in combination with etoposide plus...
Israeli drug firm Teva has agreed to settle an ongoing lawsuit levying allegations of the company’s bribery of doctors, it has emerged, with the...
Following most of the large pharmaceutical companies, Merck, Novartis and Allgeran have chosen to raise their prices.
Ipsen has secured an expansion in the UK to the existing label for Dysport (lemborexant), with the Medicines and Healthcare Products Regulatory...
The FDA has accepted a New Drug Application (sNDA) and has granted a priority review for the drug Farxiga (dapagliflozin) to reduce the risk of...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches